15-min delayed · Sep 9, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Neuropace Inc, 5 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $20.00 to $22.00, so the covering firms are broadly aligned. The average target of $21.00 sits 45% above the current $14.51. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 4 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.07 next quarter toward $-0.22 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Strong Buy
Strong Buy00%
Buy5100%
Hold00%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Neuropace Inc.
As of Sep, 5 of 5 firms rate NPCE a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
NPCE EPS & revenue forecast
EPS · NEXT QUARTER
$-0.07
Range $-0.14 – $-0.04 · 8 analysts · -14% YoY
Next period, 8 analysts expect Neuropace Inc to earn $-0.07 a share (range $-0.14 – $-0.04), versus $-0.08 a year earlier. Full-year consensus is $-0.45, growing to $-0.22 the year after.
REVENUE · NEXT QUARTER
$28.4M
Range $27.5M – $29.2M · 8 analysts · +7% YoY
Revenue is expected to reach $28.4M (range $27.5M – $29.2M), +6.8% year-over-year. Full-year consensus is $100.2M, rising to $122.7M next year.
Top analysts covering Neuropace Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NPCE.
#1
Anthony Petrone
Mizuho · Rank #86
Buy
$22.00+51.6% to target
Overall win rate
46%
+ Follow
#2
Ross Osborn
Cantor Fitzgerald · Rank #166
Buy
$16.00+10.3% to target
Overall win rate
33%
+ Follow
#3
Yi Chen
HC Wainwright & Co. · Rank #277
Buy
$20.00+37.8% to target
Overall win rate
33%
+ Follow
#4
Frank Takkinen
Lake Street · Rank #394
Buy
$20.00+37.8% to target
Overall win rate
26%
+ Follow
#5
Sarah James
Cantor Fitzgerald
Buy
$21.00+44.7% to target
Coverage
—
+ Follow
NPCE stock forecast FAQ
What is NPCE's average 12-month price target?+
The 2 analysts with a live target average $21.00 for Neuropace Inc over the next 12 months, ranging from a $22.00 high to a $20.00 low.
Is NPCE stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 5 analyst ratings, 5 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for NPCE?+
The Street-high target is $22.00 (Mizuho), and the Street-low is $20.00 (HC Wainwright & Co.). The average of all 2 active targets is $21.00.
How many Wall Street analysts cover NPCE?+
5 analysts have an active rating on Neuropace Inc, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering NPCE?+
Among analysts who currently cover NPCE, Anthony Petrone of Mizuho has the strongest overall Quantellect track record (Rank #86). Their current call is Buy with a $22.00 target.
What is Neuropace Inc's projected EPS for next quarter?+
The consensus estimate is $-0.07 per share (range $-0.14 – $-0.04) across 8 analysts. Full-year EPS is projected at $-0.45, rising to $-0.22 the following year.
How much revenue is Neuropace Inc expected to report next quarter?+
Consensus revenue is $28.4M (range $27.5M – $29.2M). Full-year revenue is projected at $100.2M, growing to $122.7M next year.
Have analysts been upgrading or downgrading NPCE lately?+
As of Sep, 5 of 5 firms rate NPCE a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NPCE calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
